Atrial Natriuretic Peptide and Three-Dimensional Echocardiography after Transcatheter Closure of Atrial Septal Defect

Jingdong Ding,Genshan Ma,Yaoyao Huang,Xiaoli Zhang,Biao Liu,Fengxiang Lu
DOI: https://doi.org/10.1186/1476-7120-6-35
2008-01-01
Cardiovascular Ultrasound
Abstract:Atrial septal defect (ASD) accounts for 10% of all congenital heart lesions and represent the third most congenital cardiac defect seen in adults. Atrial natriuretic peptide (ANP) is an important regulator of the sodium and volume homeostasis. This study was designed to investigate the changes in plasma ANP concentrations and three-dimensional echocardiography (3DE) measurements of cardiac volume in patients with ASD during transcatheter closure of defect.
What problem does this paper attempt to address?